Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Research|March 23, 2005
The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.Biochemical Pharmacology|September 12, 2012
Gli family transcription factors are drivers of patupilone resistance in ovarian cancerSimona Mozzetti, Enrica Martinelli, Giuseppina Raspaglio, et al.Gene|January 8, 2008
Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking regionGiuseppina Raspaglio, Flavia Filippetti, Silvia Prislei, et al.Molecular Pharmacology|June 20, 2003
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.Journal of Experimental & Clinical Cancer Research : CR|November 30, 2020
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancerMarta De Donato, Gabriele Babini, Simona Mozzetti, et al.Oncotarget|July 3, 2015
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancerSilvia Prislei, Enrica Martinelli, Gian Franco Zannoni, et al.The Journal of Surgical Research|August 18, 2004
The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancerPaola Concolino, Valerio Papa, Simona Mozzetti, et al.Cancer Research|December 17, 2008
Molecular mechanisms of patupilone resistanceSimona Mozzetti, Raffaella Iantomasi, Ilaria De Maria, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patientsSimona Mozzetti, Cristiano Ferlini, Paola Concolino, et al.Cancer Research|August 13, 2009
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77Cristiano Ferlini, Lucia Cicchillitti, Giuseppina Raspaglio, et al.Pageof 3